Japan Endotherapy Devices Market Size & Forecast 2025 - 2031 : Gastrointestinal Procedures and Technological Advancements | Olympus, KARL STORZ Japan

Tokyo, Japan DataM Intelligence: The Japan Endotherapy Devices Market is valued at USD 2.70 billion in 2023 and is expected to reach USD 4.44 billion by 2031, growing at a CAGR of approximately 6.5% during the forecast period from 2025 to 2031, according to DataM Intelligence.

This growth is driven by rising demand for minimally invasive diagnostic and therapeutic procedures, an aging population, increasing prevalence of gastrointestinal disorders, and continuous advancements in imaging and device technologies.

Japan: Key Industry Developments

✅ September 2025: Olympus Corporation launched next-generation endotherapy devices with improved maneuverability and high-definition imaging, enhancing procedural precision and patient safety for minimally invasive gastroenterology interventions.

✅ August 2025: Fujifilm Healthcare expanded its endotherapy portfolio, integrating AI-assisted diagnostic tools into endoscopic systems to improve lesion detection and clinical outcomes.

✅ July 2025: Pentax Medical introduced advanced single-use endotherapy devices for reduced cross-contamination risk and greater operational efficiency, promoting safer and cost-effective hospital procedures.

✅ June 2025: Nipro Corporation invested in R&D for next-generation therapeutic endoscopes featuring improved flexibility and imaging capabilities, supporting Japan's standards for minimally invasive treatment.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/japan-endotherapy-devices-market?ram

Mergers and Acquisitions (2025) - Endotherapy Devices Market:

✅ September 2025: Olympus Corporation acquired a Japanese medical imaging startup to accelerate innovation in high-definition and AI-powered endotherapy devices.

✅ August 2025: Fujifilm Healthcare formed a strategic alliance with a domestic hospital network to co-develop training programs and optimize adoption of advanced endotherapy solutions.

✅ July 2025: Pentax Medical entered a joint venture with a U.S.-based device manufacturer to expand its single-use therapeutic endoscope product range for Japanese clinics.

Key Players:

➡ Olympus Corporation - Leading provider of innovative endoscopic and endotherapy devices for minimally invasive procedures.
➡ HOYA Corporation (Pentax Medical) - Specializes in optical and endoscopic solutions for medical diagnostics and treatment.
➡ Fujifilm Holdings Corporation - Develops advanced endoscopy systems and imaging technologies for healthcare applications.
➡ Sumitomo Bakelite Co., Ltd. - Manufactures high-performance materials and components for medical device applications.
➡ Shinko Optical Co., Ltd. - Produces precision optical instruments and components used in endoscopic equipment.
➡ TOP Corporation - Offers specialized endoscopic instruments and accessories for therapeutic applications.
➡ KARL STORZ Japan K.K. - Supplies endoscopy and minimally invasive surgical instruments across various specialties.
➡ Nipro Corporation - Provides medical devices including endoscopic components and therapeutic solutions.
➡ Terumo Corporation - Develops innovative medical technologies including devices for endoscopic and therapeutic use.
➡ Hitachi Ltd. - Delivers advanced imaging and diagnostic technologies integrated with endoscopic systems.

Key FDA Approvals in 2025:

-Olympus, a leading Japan-based medical tech company, received FDA 510(k) clearance in May 2025 for its EZ1500 endoscope series featuring Extended Depth of Field (EDOF) technology, which keeps lesions sharply in focus during GI procedures.

-The EZ1500 gastroscope and colonoscope are part of the EVIS X1 system, integrating advanced imaging technologies like Narrow Band Imaging, Texture and Color Enhancement Imaging, and Red Dichromatic Imaging, enhancing lesion detection.

-The lightweight ErgoGripTM design improves handling and scope maneuverability, especially for users with smaller hands.

-This FDA clearance marks a major advance in endoscopy from Japan, setting new standards for gastrointestinal diagnosis and treatment.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=japan-endotherapy-devices-market?ram (Purchase 2 or more Reports and get 50% Discount)

Key Segments:

➥ By Product Type: Endoscopes, Endoscopic Operative Devices, Endoscopic Visualization Devices. Among these, endoscopes dominate the market due to their extensive use in diagnostic and surgical procedures.

➥ By Application: Gynaecology Endoscopy, Gastrointestinal (GI) Endoscopy, Bronchoscopy, Urology Endoscopy, Arthroscopy, and Laparoscopy. GI endoscopy holds a major market share owing to the increasing prevalence of gastrointestinal disorders.

➥ By End User: Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics. Hospitals lead the segment, supported by advanced healthcare infrastructure and a high volume of endoscopic treatments.

Latest Industry Trends and News:

-AI-powered diagnostic tools and digital monitoring are enhancing clinical accuracy and operational efficiency in endotherapy.

-Expansion of single-use endotherapy devices is improving patient safety and reducing hospital-acquired infection risks.

-Collaborations between manufacturers and healthcare institutions are driving next-generation endotherapy device innovation.

-Training initiatives and digital integration are enhancing clinical adoption rates and patient outcomes in Japan.

Speak to Our Analyst and get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/japan-endotherapy-devices-market?ram

Market Dynamics and Growth Drivers:

-Rising prevalence of gastrointestinal diseases and chronic disorders is boosting endotherapy device adoption.

-Increasing preference for minimally invasive healthcare procedures due to faster recovery times and reduced complications.

-Technological advances in endoscopic visualization, device flexibility, and robotics are enhancing safety and clinical outcomes.

-Growth in hospital, specialty clinic, and outpatient care center infrastructure increases accessibility to endotherapy treatments.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.